SCHEMBL8884872

SCHEMBL8884872

Cc1cc2c(cc1C#Cc1ccc(CC(=O)O)s1)C(C)(C)CCO2

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 5/20 0.42
CYP26B1 Q9NR63 3/20 0.42
RXRA P19793 4/20 0.38
HNF4A P41235 2/20 0.38
RARA P10276 4/20 0.37
RARB P10826 4/20 0.37
RARG P13631 4/20 0.37
RXRB P28702 2/20 0.35
RXRG P48443 2/20 0.35
AKR1B1 P15121 1/20 0.33
FFAR1 O14842 1/20 0.32
SSTR5 P35346 3/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.31
MAP3K14 Q99558 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6664577 0.89 CYP26A1 (0.41) CYP26A1CYP26B1RXRAHNF4ARARA
SCHEMBL9137414 0.88 RXRA (0.39) CYP26A1CYP26B1RXRAHNF4ARARA
SCHEMBL6668788 0.86 CYP26A1 (0.39) CYP26A1CYP26B1RXRAHNF4ARARA
SCHEMBL8874120 0.84 AKR1B1 (0.38) CYP26A1CYP26B1RXRARXRBRXRG
SCHEMBL6664761 0.83 CYP26A1 (0.48) CYP26A1CYP26B1RXRAHNF4ARARA
SCHEMBL6668958 0.83 CYP26A1 (0.37) CYP26A1CYP26B1RXRAHNF4ARARA
SCHEMBL9142284 0.82 RXRA (0.41) CYP26A1CYP26B1RXRAHNF4ARARA
SCHEMBL6664865 0.82 RARB (0.37) CYP26A1CYP26B1RXRARARARARB
SCHEMBL6665664 0.81 CYP26A1 (0.36) CYP26A1CYP26B1RXRAHNF4ARARA
SCHEMBL6668902 0.81 RARA (0.38) CYP26A1CYP26B1RXRAHNF4ARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5602130-A ORNITHINE DECARBOXYLASE ENZYME INHIBITOR TREATING SKIN DISORDER, INHIBITING CELL HYPERPROLIFERATION ALLERGAN 1997-02-11 US disclosed
US-5380877-A Psoriasis treatment; retinoic acid-like activity ALLERGAN, INC. (US) 1995-01-10 US disclosed
US-5354752-A A dimethylthiochroman or dimethylchroman-6-yl-ethynyl-pyridazin- or pyrimidin- or pyrazin-for treating skin disorders psoriasis ALLERGAN, INC. (US) 1994-10-11 US disclosed
US-5348972-A In treatment of skin disorders such as acne and psoriasis ALLERGAN, INC. (US) 1994-09-20 US disclosed
US-5234926-A Skin disorders ALLERGAN, INC. (US) 1993-08-10 US disclosed
EP-0284288-B1 DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID LIKE ACTIVITY ALLERGAN, INC (US) 1992-05-27 EP disclosed
US-5089509-A Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity ALLERGAN, INC. (US) 1992-02-18 US disclosed
EP-0284288-A1 Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity ALLERGAN, INC (US) 1988-09-28 EP disclosed